1-9 of 9
Yan Leyfman
Close
Sort by
Journal Articles

The Impact of a Virtual Platform to Reduce Hematology-Oncology Educational Disparities Amongst Healthcare Professionals in Lower Socioeconomic Regions Globally

Yan Leyfman, Gayathri P. Menon, Muskan Joshi, Maduri Balasubramanian, Keira P. Smith, Elizabeth J. Heller, Helena S. Coloma, Alexandra Van de Kieft, Ahmed Hashim, Harshal Chorya, Rabab H. Abbas, Gabriele Alves, Jenna Ghazal, Steven Wilson, Shane Grivna, Chandler Howard Park
Journal: Blood
Blood (2023) 142 (Supplement 1): 7266.
https://doi.org/10.1182/blood-2023-184391
Published: 2023
Journal Articles

Exosomal Vesicles: A Therapeutic Strategy Against Severe Sars-Cov-2 in Multiple Myeloma Patients

Yan Leyfman, Muskan Joshi, Gayathri P. Menon, Alexandra Van de Kieft, Chandler Howard Park
Journal: Blood
Blood (2023) 142 (Supplement 1): 7181.
https://doi.org/10.1182/blood-2023-185101
Published: 2023
Journal Articles

Bendamustine Bridging Versus Standard of Care Chemotherapy on Toxicity Profile for Multiple Myeloma Patients Undergoing CAR T Cell Therapy

Yan Leyfman, Sridevi Rajeeve, Tianxiang Sheng, Marcio Diniz, Shambavi Richard, Sundar Jagannath, Adriana C Rossi
Journal: Blood
Blood (2023) 142 (Supplement 1): 6861.
https://doi.org/10.1182/blood-2023-181420
Published: 2023
Journal Articles

Empowering Global Hematology-Oncology Education: Assessing the Impact of a 1.5-Year Virtual Platform in Combating Miseducation & Inequity

Yan Leyfman, Alexandra Van de Kieft, Muskan Joshi, Gayathri P. Menon, Maduri Balasubramanian, Elizabeth J. Heller, Keira P. Smith, Ahmed Hashim, Helena S. Coloma, Gabriele Alves, William B. Wilkerson, Chandler Howard Park
Journal: Blood
Blood (2023) 142 (Supplement 1): 7256.
https://doi.org/10.1182/blood-2023-174006
Published: 2023
Journal Articles

The Development of an Ontology Platform to Detect Serine Protease Involvement in COVID-19-Induced Co-Morbid BALT Lymphoma

Yan Leyfman, Samarth Sandeep, Kirk McGregor, Chandler Howard Park
Journal: Blood
Blood (2022) 140 (Supplement 1): 11997–11998.
https://doi.org/10.1182/blood-2022-159853
Published: 2022
Journal Articles

Development of a Virtual Platform to Combat Global Inequity in Oncological Education

Yan Leyfman, Shubhadarshini G. Pawar, William B. Wilkerson, Muskan Joshi, Chandler Howard Park
Journal: Blood
Blood (2022) 140 (Supplement 1): 13097–13098.
https://doi.org/10.1182/blood-2022-159803
Published: 2022
Journal Articles

Social Media Validation for Pre-Screened Ontologies As a Driver for Biomolecular Interaction Significance in COVID-19 and Hematological Malignancies

Yan Leyfman, Samarth Sandeep, Peter Rizk, Carlo Khoury, Chandler Howard Park
Journal: Blood
Blood (2021) 138 (Supplement 1): 4936.
https://doi.org/10.1182/blood-2021-151709
Published: 2021
Journal Articles

Expectant Management of Extranodal Marginal Zone Lymphoma of Bronchial-Associated Lymphoid Tissue (BALT)

Yan Leyfman, BS, Erel Joffe, MDMSc, Esther Drill, PhD, Sridevi Rajeeve, MD, Andrew D. Zelenetz, MD PhD, Maria Lia Lia Palomba, Craig H. Moskowitz, Carol S. Portlock, MD, Ariela Noy, MD, Steven M. Horwitz, MD, Alison J. Moskowitz, MD, Paul A. Hamlin, MD, Matthew J Matasar, MD, Anita Kumar, MD, Gottfried R. von Keudell, MD PhD, Connie Lee Batlevi, MD PhD, Anas Younes, MD, David J. Straus, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2826.
https://doi.org/10.1182/blood-2019-123257
Published: 2019
Journal Articles

The Development of a qPCR Assay for the Evaluation of the Dendritic Cell Chimeric Antigen Receptor Transcriptome

Yan Leyfman, BS, Anthony Daniyan, MD, Renier J. Brentjens, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5895.
https://doi.org/10.1182/blood.V128.22.5895.5895
Published: 2016